Faculty profile

Alexandre Prat

ResearcherNeurosciencesUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Alexandre Prat

Researcher

Neurosciences

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
84 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.
Principal investigator on 14 research grants (14 CIHR), most recently in 2025.
Supervisor on 5 trainee awards (5 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

173

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Multiple Sclerosis Blood-Brain Barrier Neuroimmunology Experimental Autoimmune Encephalomyelitis Lymphocytes Cellular Adhesion Molecules Blood Brain Barrier Endothelial Cells

Latest papers

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.
Multiple sclerosis (Houndmills, Basingstoke, England) · 2026
Causal effects of multiple sclerosis therapies in left-truncated registry data.
Multiple sclerosis (Houndmills, Basingstoke, England) · 2026
Antigen presentation by CD40+MHC-II+ astrocytes promotes CNS autoimmunity.
Nature · 2026

All 173 publications

Latest funding

Targeting the novel cell adhesion molecule DICAM to curb myeloid cell-associated neuroinflammation
CIHR · 2025 · Nominated PI
$1,093,950
Mannose receptor C type 2 is a novel mediator of pro-inflammatory T lymphocyte migration across central nervous system barriers
CIHR · 2024 · Nominated PI
$918,000
Canada Research Chair - Tier 1
CIHR · 2022 · Nominated PI
$1,400,000

All 25 grants and awards

From the 150 most recent of 173 publications.

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

Nesbitt C, Sanfilippo P, Zhu C, Ozakbas S, Prat A, Girard M, Duquette P, Kalincik T, Roos I, Buzzard K, Skibina O, Foschi M, Surcinelli A, Lechner-Scott J, Patti F, Kermode AG, Fabis-Pedrini M, Carroll WM, Hodgkinson S, Grand'Maison F, Havrdova EK, Hradilek P, Habek M, Maimone D, Alroughani R, Vachova M, van Pesch V, Macdonell R, Spitaleri D, Khoury SJ, Gerlach O, de Gans K, McCombe P, Van Der Walt A, Butzkueven H, Jokubaitis V

Multiple sclerosis (Houndmills, Basingstoke, England)2026

DOI: 10.1177/13524585261460658 PMID: 42543909

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Haile DC, Diouf I, Ozakbas S, Horakova D, Havrdova EK, Patti F, Eichau S, Alroughani R, Lugaresi A, Tomassini V, Prat A, Girard M, Terzi M, Yamout B, Khoury SJ, Grammond P, Blanco Y, Shaygannejad V, Foschi M, Surcinelli A, Neri S, Weinstock-Guttman B, Prevost J, Amato MP, Barnett M, Gerlach O, John N, Kermode AG, Fabis-Pedrini M, Carroll WM, van der Walt A, Butzkueven H, van Pesch V, Soysal A, Gouider R, Mrabet S, Spitaleri D, Cartechini E, Maimone D, Ampapa R, Laureys G, Ramo-Tello C, Di Gregorio M, Lapointe E, Slee M, Karabudak R, Garber J, Altintas A, Hodgkinson S, Sanchez-Menoyo JL, Castillo-Triviño T, Habek M, Al-Asmi A, Al-Harbi T, Csepany T, Cárdenas-Robledo S, Taylor B, Foong YC, Willekens B, Shalaby N, Moore F, McGuigan C, Baghbanian SM, Massey J, Hardy TA, Ramanathan S, Gross-Paju K, Gray O, Decoo D, Shaw C, Simu M, Rozsa C, Stuart EA, Sharmin S, Roos I, Kalincik T

Multiple sclerosis (Houndmills, Basingstoke, England)2026

DOI: 10.1177/13524585261459943 PMID: 42479470

Antigen presentation by CD40+MHC-II+ astrocytes promotes CNS autoimmunity.

Lee JH, Li Z, Soto JS, Kim AR, Illouz T, Polonio CM, Kilian M, Kenison JE, Schüle AM, Akl CF, Lee HG, Andersen BM, Ye JJ, Rone JM, Piester G, Srun L, Martinez J, Danko A, Lee J, Heo TH, Chung EN, Oetjen LK, Duart-Abadia P, Koo N, Perrimon N, Wheeler MA, Khakh BS, Zandee SEJ, Prat A, Quintana FJ

Nature2026

DOI: 10.1038/s41586-026-10860-6 PMID: 42557325

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Zhu C, Vukusic S, Kalincik T, Mathey G, Kermode AG, Maillart E, Lechner-Scott J, Le Page E, Roos I, Ciron J, Kubala Havrdova E, Horakova D, De Sèze J, Skibina O, Ruet A, Yetkin MF, Labauge P, Habek M, Kwiatkowski A, Baghbanian SM, Zephir H, Meca-Lallana JE, Valero López G, Papeix C, Gerlach O, Defer G, Fabis-Pedrini M, Carroll WM, Lebrun-Frenay C, Hodgkinson S, Moreau T, Laureys G, Laplaud DA, Prat A, Berger E, Lapointe E, Clavelou P, Ampapa R, Thouvenot E, Stetkarova I, Heinzlef O, Stourac P, Pelletier J, Foschi M, Al Khedr A, D'Amico E, Casez O, Alroughani R, Bourre B, Brecl Jakob G, Creange A, Ozakbas S, David T, John N, Magy L, Camdessanché JP, Moulin S, Doghri I, Sarov Riviere M, Hankiewicz K, Pottier C, Manchon E, Aboab J, Tchikviladze M, Nifle C, Merlo D, Monif M, Zhou Z, Foong YC, Jokubaitis V, van der Walt A, Butzkueven H, OFSEP and MSBase investigators

Journal of neurology, neurosurgery, and psychiatry2026

DOI: 10.1136/jnnp-2026-339059 PMID: 42601218

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Roos I, Sharmin S, Horakova D, Kubala Havrdova E, Libertinova J, Vachova M, Alroughani R, Boz C, Rous Z, Buzzard K, Skibina O, Peterka M, Hradilek P, Mares M, Coles A, Brown JWL, Eichau Madueño S, Foschi M, Prevost J, Terzi M, Prat A, Girard M, Meca-Lallana JE, John N, Blanco Y, van der Walt A, Butzkueven H, Recmanova E, Laureys G, Ampapa R, Macdonell R, Pavelek Z, Khoury SJ, D'Amico E, Gerlach O, Van Pesch V, Maimone D, Romero-Ferrando B, McCombe PA, Mrabet S, Willekens B, Cárdenas-Robledo S, Ramo-Tello C, Stourac P, Houskova J, Shaygannejad V, Hodgkinson S, Cartechini E, Kermode AG, Fabis-Pedrini M, Carroll WM, Slee M, Sánchez-Menoyo JL, Al-Asmi A, Mathey G, Giannesini C, Michel L, Ciron J, De Sèze J, Ruet A, Kwiatkowski A, Zephir H, Papeix C, Lebrun-Frenay C, Moreau T, Berger E, Clavelou P, Pelletier J, Casez O, Bourre B, Wahab A, Magy L, Camdessanché JP, Doghri I, Tchikviladze M, Sellebjerg F, Romme Christensen J, Jensen HB, Illes Z, Bramow S, Rasmussen PV, Stilund ML, Schäfer J, Kant M, Weglewski A, Vukusic S, Magyari M, Laplaud DA, Kalincik T, MSBase, OFSEP and Danish MS Registries

Journal of neurology, neurosurgery, and psychiatry2026

DOI: 10.1136/jnnp-2026-338424 PMID: 42161588

Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis.

Bigotte M, Groh AMR, Afanasiev E, Wong V, Lancon K, Yaqubi M, Creeggan F, Sinott A, Pei J, Moore CS, Harroud A, Schneider R, Séguéla P, Charabati M, Tea F, Fournier AP, Wang YC, Ragoussis J, Prat A, Thebault S, Zandee S, Stratton JA

Brain : a journal of neurology2026

DOI: 10.1093/brain/awaf440 PMID: 41277219

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Daruwalla C, Kremler C, Patti F, Ozakbas S, Boz C, Lechner-Scott J, Surcinelli A, Foschi M, Khoury SJ, Butzkueven H, van der Walt A, Rous Z, Habek M, Meca-Lallana JE, Lopez GV, Alroughani R, Blanco Y, Laureys G, Skibina O, Buzzard K, Gray O, McCombe P, Maimone D, Duquette P, Girard M, Prat A, Sanchez-Menoyo JL, van Pesch V, Soysal A, Amato MP, Grand'Maison F, Wilton J, Van Wijmeersch B, Gerlach O, Lugaresi A, Tomassini V, De Luca G, Taylor B, Foong YC, John N, Cárdenas-Robledo S, Hodgkinson S, Macdonell R, Willekens B, Garber J, D'Amico E, Terzi M, Houskova J, Lapointe E, Al-Asmi A, Barnett M, Stetkarova I, Gouider R, Mrabet S, Csepany T, McGuigan C, Gross-Paju K, Kuhle J, Castillo-Triviño T, Kerrigan S, Tolkovsky AM, Wardle M, Cunniffe NG, Roos I, Madley-Dowd P, Coles A, Kalincik T, Sterne JAC, William Brown JL, MSBase study group

Brain : a journal of neurology2026

DOI: 10.1093/brain/awag252 PMID: 42496160

Gaining biological insights through supervised data visualization.

Rhodes JS, Aumon A, Morin S, Girard M, Larochelle C, Brunet-Ratnasingham E, Pagliuzza A, Marchitto L, Zhang W, Cutler A, Grand'Maison F, Zhou A, Finzi A, Chomont N, Kaufmann DE, Zandee S, Prat A, Wolf G, Moon KR

Nature computational science2026

DOI: 10.1038/s43588-026-00999-7 PMID: 42380342

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Roos I, Sharmin S, Ozakbas S, Alroughani R, Eichau S, Grand'Maison F, Boz C, Lechner-Scott J, Buzzard K, Prat A, Khoury SJ, Grammond P, van der Walt A, Blanco Y, Foschi M, Soysal A, Barnett M, Prevost J, Terzi M, Gerlach O, Macdonell R, Sa MJ, Spitaleri D, Laureys G, van Pesch V, John N, Cartechini E, Gouider R, Maimone D, Ramo-Tello C, Hodgkinson S, Slee M, McCombe P, Garber J, Sanchez-Menoyo JL, Al-Asmi A, Kermode AG, Lapointe E, Shaygannejad V, Van Wijmeersch B, Willekens B, Castillo-Triviño T, Taylor B, Mathey G, Le Page E, De Seze J, Ruet A, Clavelou P, Berger E, Zephir H, Kwiatkowski A, Pelletier J, Moreau T, Labauge P, Ciron J, Lebrun-Frenay C, Papeix C, Defer G, Laplaud DA, Thouvenot E, Stankoff B, Maillart E, Al-Khedr A, Bourre B, Casez O, Dos Santos A, Camdessanche JP, Hankiewicz K, Wahab A, Cabre P, Heinzlef O, Pottier C, Moulin S, Magy L, Labeyrie C, Doghri I, Vukusic S, Kalincik T, MSBase and OFSEP Study Groups

CNS drugs2026

DOI: 10.1007/s40263-026-01287-8 PMID: 41935174

Cerebellar magnetization transfer ratio and its relationship to clinical outcomes in radiologically isolated syndrome and multiple sclerosis.

Lee LE, Khoury M, Churchill N, Vavasour I, Johnson P, Traboulsee A, Lynd LD, Prat A, Zhang Y, Feinstein A, Graham SJ, Hodaie M, Kolind S, Schweizer TA, Oh J, CanProCo Study Group

Multiple sclerosis (Houndmills, Basingstoke, England)2026

DOI: 10.1177/13524585261450926 PMID: 42334399

Something wrong or missing on this profile? Suggest a correction

Alexandre Prat

Research

Latest papers

Latest funding

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Antigen presentation by CD40+MHC-II+ astrocytes promotes CNS autoimmunity.

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis.

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Gaining biological insights through supervised data visualization.

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Cerebellar magnetization transfer ratio and its relationship to clinical outcomes in radiologically isolated syndrome and multiple sclerosis.

Frequent collaborators

Pierre Duquette

Nathalie Arbour

Catherine Larochelle

Jiwon Oh

Jack Antel

Amit Bar-Or

Shannon Kolind

Anthony Traboulsee

Penelope Smyth

Nicolas Chomont

Nicolas Chomont

Myriam Srour

Myriam Srour

Elie Haddad

Roy Dudley

Yunyan Zhang

Fabrizio Giuliani

Julien Cohen-Adad

Scott Patten

Mojgan Hodaie

Samuel David

Madeleine Durand

Adriana Di Polo

Christine Vande Velde

Didier Jutras-Aswad

Jennifer Gommerman

Pierre Drapeau

Dang Nguyen

Karen Mossman

Yahye Merhi

Jiangping Wu

Lionel Carmant

Marie-Claude Rousseau

Dang Nguyen

Serge Rivest